Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
BRITISH JOURNAL OF CANCER
Rivista
Codice:
E025328
ISSN:
0007-0920
Dati Generali
Dati Generali
Pubblicazioni (52)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
Articolo
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
Articolo
A taxonomy of early diagnosis research to guide study design and funding prioritisation
Articolo
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
Articolo
An unmet need: tailoring extended adjuvant endocrine therapy.
Articolo
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy
Articolo
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
Articolo
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy
Articolo
Characterisation of circulating chromogranin A in human cancer patients
Articolo
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
Articolo
Comment on 'Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome'
Articolo
Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England
Articolo
Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer?
Articolo
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
Articolo
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
Articolo
Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
Articolo
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
Articolo
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
Articolo
Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae
Articolo
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
Articolo
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases
Articolo
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases
Articolo
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
Articolo
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
Articolo
Incidence trends for twelve cancers in younger adults—a rapid review
Articolo
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary
Articolo
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial
Articolo
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
Articolo
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
Articolo
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
Articolo
NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells.
Articolo
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
Articolo
PHASE II STUDY OF NGR-hTNF IN COMBINATION WITH DOXORUBICIN IN RELAPSED OVARIAN CANCER PATIENTS
Articolo
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
Articolo
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Articolo
Pazopanib and sunitinib trigger autophagic and non autophagic death of bladder tumor cells
Articolo
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
Articolo
Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumors.
Articolo
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumors
Articolo
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
Articolo
Pre-treatment neutrophil to lymphocyte ratio as an independent prognostic factor in patients with treated with everolimus for metastatic renal cell carcinoma
Articolo
Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
Articolo
Response to ‘Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer’
Articolo
Second line treatment for primary central nervous system lymphoma
Articolo
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
Articolo
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
Articolo
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Articolo
Temozolomide as salvage treatment in primary brain lymphomas
Articolo
The effect of metformin on apoptosis in a breast cancer presurgical trial
Articolo
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
Articolo
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
Articolo
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
